Skip to main content
Journal cover image

Consequences and Predictors of Prolonged Tissue Expander Duration in Breast Reconstruction.

Publication ,  Journal Article
Langdell, HC; Sergesketter, AR; Biswas, S; Morris, M; Zhang, GX; Atia, A; Phillips, BT
Published in: J Reconstr Microsurg
October 2023

BACKGROUND:  Tissue expanders (TEs) are temporary devices used in breast reconstruction, which are generally removed within 1 year. There is a paucity of data regarding the potential consequences when TEs have longer indwelling times. Thus, we aim to determine whether prolonged TE implantation length is associated with TE-related complications. METHODS:  This is a single-center retrospective review of patients who underwent TE placement for breast reconstruction from 2015 to 2021. Complications were compared between patients who had a TE for >1 year and <1 year. Univariate and multivariate regressions were used to evaluate predictors of TE complications. RESULTS:  A total of 582 patients underwent TE placement and 12.2% had the expander for >1 year. Adjuvant chemoradiation, body mass index (BMI), overall stage, and diabetes predicted the duration of TE placement (p ≤ 0.006). Rate of return to the operating room was higher in patients who had TEs in place >1 year (22.5 vs 6.1%, p < 0.001). On multivariate regression, prolonged TE duration predicted an infection requiring antibiotics, readmission, and reoperation (p < 0.001). Reasons for longer indwelling times included need for additional chemoradiation (79.4%), TE infections (12.7%), and requesting a break from surgery (6.3%). CONCLUSION:  Indwelling TEs for >1 year are associated with higher rates of infection, readmission, and reoperation even when controlling for adjuvant chemoradiation. Patients with diabetes, a higher BMI, advanced cancer stage, and those requiring adjuvant chemoradiation should be advised they may require a TE for a longer time interval prior to final reconstruction.

Duke Scholars

Published In

J Reconstr Microsurg

DOI

EISSN

1098-8947

Publication Date

October 2023

Volume

39

Issue

8

Start / End Page

655 / 663

Location

United States

Related Subject Headings

  • Tissue Expansion Devices
  • Surgery
  • Retrospective Studies
  • Postoperative Complications
  • Mastectomy
  • Mammaplasty
  • Humans
  • Female
  • Diabetes Mellitus
  • Breast Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Langdell, H. C., Sergesketter, A. R., Biswas, S., Morris, M., Zhang, G. X., Atia, A., & Phillips, B. T. (2023). Consequences and Predictors of Prolonged Tissue Expander Duration in Breast Reconstruction. J Reconstr Microsurg, 39(8), 655–663. https://doi.org/10.1055/a-2039-1305
Langdell, Hannah C., Amanda R. Sergesketter, Sonali Biswas, Miranda Morris, Gloria X. Zhang, Andrew Atia, and Brett T. Phillips. “Consequences and Predictors of Prolonged Tissue Expander Duration in Breast Reconstruction.J Reconstr Microsurg 39, no. 8 (October 2023): 655–63. https://doi.org/10.1055/a-2039-1305.
Langdell HC, Sergesketter AR, Biswas S, Morris M, Zhang GX, Atia A, et al. Consequences and Predictors of Prolonged Tissue Expander Duration in Breast Reconstruction. J Reconstr Microsurg. 2023 Oct;39(8):655–63.
Langdell, Hannah C., et al. “Consequences and Predictors of Prolonged Tissue Expander Duration in Breast Reconstruction.J Reconstr Microsurg, vol. 39, no. 8, Oct. 2023, pp. 655–63. Pubmed, doi:10.1055/a-2039-1305.
Langdell HC, Sergesketter AR, Biswas S, Morris M, Zhang GX, Atia A, Phillips BT. Consequences and Predictors of Prolonged Tissue Expander Duration in Breast Reconstruction. J Reconstr Microsurg. 2023 Oct;39(8):655–663.
Journal cover image

Published In

J Reconstr Microsurg

DOI

EISSN

1098-8947

Publication Date

October 2023

Volume

39

Issue

8

Start / End Page

655 / 663

Location

United States

Related Subject Headings

  • Tissue Expansion Devices
  • Surgery
  • Retrospective Studies
  • Postoperative Complications
  • Mastectomy
  • Mammaplasty
  • Humans
  • Female
  • Diabetes Mellitus
  • Breast Neoplasms